Figure 1

Patient flow in the ASTRIO study. End of treatment (EOT) was evaluated at week 24 or early discontinuation, if applicable.
Patient flow in the ASTRIO study. End of treatment (EOT) was evaluated at week 24 or early discontinuation, if applicable.